Disclaimer
Last updated: April 2026
Overview
Pepteligence is an educational and informational reference platform. All content published on this site — including peptide profiles, mechanism descriptions, dosing ranges, research summaries, community experience reports, and any other material — is provided for general educational and informational purposes only. Nothing on this site constitutes, or should be construed as, medical advice, diagnosis, treatment, or a recommendation to take any specific action regarding any substance or health condition.
Not Medical Advice
The information on Pepteligence does not replace the judgment of a qualified healthcare provider. You should always consult a licensed physician, pharmacist, or other qualified healthcare professional before making any decision related to your health, including any decision to use, avoid, or discontinue any substance discussed on this site.
Never disregard professional medical advice, delay seeking it, or change your treatment on the basis of anything you read on Pepteligence. If you have or suspect you have a medical condition, contact a qualified healthcare provider immediately.
Individual responses to peptides and research compounds vary significantly based on health status, genetics, concurrent medications, and many other factors that cannot be assessed through a general-purpose information platform. What is reported in research studies or by community members may not apply to your situation.
Research Chemicals and Regulatory Status
Many of the substances discussed on Pepteligence — including BPC-157, TB-500, and Ipamorelin — are research chemicals that are not approved by the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), or equivalent regulatory bodies for clinical human therapeutic use. These substances lack the clinical trial data required for regulatory approval and their safety and efficacy profiles in humans are not fully established.
Other substances discussed — such as Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound) — are FDA-approved only for specific indications and are available exclusively by prescription. Discussing these substances in an educational context does not imply endorsement of off-label use.
Pepteligence provides educational information to support an understanding of the research landscape. We do not recommend, encourage, or endorse the use of any substance outside of properly authorised clinical or research settings. Users are solely responsible for understanding and complying with all applicable laws and regulations in their jurisdiction.
Not a Distributor
Pepteligence does not sell, distribute, supply, or facilitate the purchase of any peptide, research chemical, pharmaceutical, supplement, or any other substance. We do not endorse, recommend, or affiliate with any vendor, supplier, compounding pharmacy, or seller of any kind.
Outbound links on Pepteligence — including links to PubMed, academic journals, and research databases — are provided for educational reference only. The presence of a link does not constitute an endorsement of the linked site, its content, or any products or services it may offer.
No Doctor-Patient Relationship
Use of this site does not create a doctor-patient relationship, a pharmacist-patient relationship, or any other professional healthcare relationship between you and Pepteligence, its operators, contributors, or any individual associated with the platform. No communications through this site — including any experience submission or community content — should be treated as professional medical advice or consultation.
User Experience Reports
Pepteligence may display user-submitted experience reports describing individual, self-reported experiences with various substances. This content reflects the personal experiences of anonymous individual contributors and has not been verified, validated, or endorsed by Pepteligence. User experience reports are not medical outcomes, clinical data, or controlled research findings. They do not predict results for any other individual and must not be interpreted as treatment recommendations.
User-submitted content is third-party speech published under 47 U.S.C. § 230 (the Communications Decency Act). Pepteligence is not the author of user-submitted content and is not responsible for its accuracy or consequences.
Accuracy of Information
We endeavour to cite peer-reviewed research and accurately represent the state of the scientific literature. However, peptide science is a rapidly evolving field. We make no warranties — express or implied — regarding the completeness, accuracy, timeliness, or current relevance of any content on this site. Research findings are subject to revision as new data emerges. Content may not reflect the most recent regulatory changes, publication retractions, or emerging safety signals.
Age Requirement
Pepteligence is intended for adults aged 18 and over. By accessing this site, you represent that you are at least 18 years of age. If you are under 18, please exit the site immediately. We do not knowingly provide content to or collect information from minors.
Legal Compliance
The legal status of research chemicals and peptides varies by country, state, and jurisdiction. It is your sole responsibility to understand and comply with all applicable laws and regulations in your jurisdiction before taking any action in relation to any substance discussed on this site. Pepteligence makes no representations about the legality of any substance in any particular jurisdiction. Accessing educational information about a substance does not imply that possession, purchase, or use of that substance is legal where you are located.
User-Submitted Content
Pepteligence allows users to submit first-person accounts of their experiences with peptides and related compounds. These submissions are individual anecdotes — not controlled clinical observations, not verified medical records, and not evidence of efficacy or safety for any person other than the submitter.
User-submitted content is verified only to the extent that submitters provide a contact email and attest to the authenticity of their own experience at the time of submission. We do not independently verify any health claims, outcome reports, dosing information, or sourcing claims made in submissions. Results described by one user should not be expected to apply to any other individual.
All submissions are reviewed by a human moderator before appearing publicly. We publish or reject submissions without materially editing their content, in order to maintain the integrity of user speech and consistency with 47 U.S.C. § 230 (the Communications Decency Act). We reserve the right to remove any submission that violates our Terms of Service, appears fraudulent, or promotes specific vendors.
Always consult a qualified healthcare provider before using any peptide or compound. User experiences on this platform are not a substitute for professional medical advice.
Contact
Questions about this disclaimer can be directed to contact@pepteligence.com.